sodium-glucose cotransporter-2 inhibitor - Globe Thesis

Keyword [sodium-glucose cotransporter-2 inhibitor] Result: 1 - 19 \| Page: 1 of 1
1.	Empagliflozin And Other Antidiabetic Agents For Type 2 Diabetes: A Systematic Review
2.	The Effect Of Dapagliflozin On Blood Lipids Profile In Patients With Type 2 Diabetes:A Meta-analysis
3.	Short-term Clinical Efficacy And Safety Of Dapagliflozin In The Treatment Of Type 2 Diabetes
4.	Clinical Investigation Of Renoprotective Effect And Its Mechanism Of Sodium-glucose Cotransporter 2 Inhibitor In Type 2 Diabetes Mellitus
5.	Development Of A Novel Model For Clinical Diagnosis And Evaluation Of ACEI/ARB Therapy In Diabetic Nephropathy
6.	The Study On Prognosis Of Diabetic Nephropathy Underlying Renal Pathologic Lesions
7.	Clinical Observation Of Sodium-glucose Cotransporter 2 Inhibitor In The Treatment Of Type 2 Diabetes Mellitus With Chronic Kidney Disease
8.	The Effect Of SGLT2 Inhibitor On Blood Lipid Profile In Adult Patients With Type 2 Diabetes Mellitus: A Meta-analysis
9.	The Effect Of Sodium-glucose Co-transporter 2 Inhibitiors On Albuminuria In Patients With Type 2 Diabetes: A Systematic Review
10.	Basic Study On The Application Effect Of SGLT2i-Cagliazin On Nephrotic Syndrome
11.	Efficacy And Prognosis Analysis Of Sodium-glucose Cotransporter-2 Inhibitor In The Treatment Of Heart Failure With Reduced Ejection Fraction
12.	Study On The Efficacy Of SGLT2 Inhibitors In The Treatment Of Type 2 Diabetes Mellitus Complicated With NAFLD
13.	The Effect Of Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin On Cardiac Function In A Normoglycemic Rabbit Model Of Chronic Heart Failure And Its Mechanism
14.	Study On The Clinical Efficacy Of HFrEF Patients With Renal Insufficiency In Dapagliflozin
15.	Effects Of SGLT-2i On HbA1c And BP In Patients With Type 2 Diabetes Mellitus And Hypertension In Xining Area
16.	Effects Of SGLT-2 Inhibitors On Body Compositions In Type 2 Diabetes Mellitus:Meta-analysis
17.	The Study Of The Effect Of SGLT2 Inhibitors In Prevent Contrast-induced Acute Kidney Injury
18.	Effects Of SGLT2i On Cardiovascular Outcomes In Patients With Heart Failure With Mid-range Ejection Fraction Based On Propensity Score Matching
19.	The Mechanism Of Anti-Atherosclerosis Of Dapagliflozin,an SGLT2 Inhibitor
<<First <Prev Next> Last>> Jump to